P15INK4B is not mutated in adult familial myelodysplastic syndromes [6]

British Journal of Haematology

Volumn 119, Issue 1, 2002, Pages 277-279

  Cameron, Elizabeth ^a   Mijovic, Aleksandar ^b   Herman, James G ^a   Baylin, Stephen B ^a   Pradhan, Anjala ^b   Mufti, Ghulam J ^b   Rassool, Feyruz V ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adult familial MDS; P15INK4B gene

Indexed keywords

PROTEIN P15; PROTEIN P16INK4A;

ADULT; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; EXON; FAMILIAL DISEASE; FEMALE; GENE AMPLIFICATION; GENE DISRUPTION; GENE INACTIVATION; GENE LOCATION; GENE LOSS; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; LETTER; LEUKEMIA; MALE; METHYLATION; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; CHROMOSOME 9; GENETICS; MUTATION; PEDIGREE;

ADULT; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; MUTATION; MYELODYSPLASTIC SYNDROMES; PEDIGREE;

EID: 0035986825     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.37707.x     Document Type: Letter

References (6)

1. Herman, J.G., Civin, C., Issa, J.-P.J., Collector, M., Sharkus, S.J. & Baylin, S.B. (1997) Distinct patterns of inactivation of P15INK4b and P16INK4a characterize the major types of hematologic malignancies. Cancer Research, 57, 837-841.
2. Hussussian, C.J., Struewing, J.P., Goldstein, A.M., Higgins, P.A., Ally, D.S., Sheahan, M.D., Clark, W.H., Tucker, M.A. & Dracopoli, N.C. (1994) Germline mutations in familial melanoma. Nature Genetics, 8, 15-21.
3. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day, III, R.S., Johnson, B.E. & Skolnick, M.H. (1994) A cell cycle regulator potentially involved in the genesis of many tumor types. Science, 264, 436-440.
4. Mijovic, A. & Mufti, G.J. (1998) Familial syndromes (f-MDS): towards the genetic basis of leukaemia. British Journal of Haematology, 102, 1354.
5. Mufti, G.J. (1992) A guide to risk assessment in the primary myelodysplastic syndrome. Hematology Oncology Clinics of North America, 6, 587-590.
6. Nakamaki, T., Bartram, C., Seriu, T., Kahan, J., Fukuchi, K., Tsuruoka, N., Janssen, J.W., Miller, C.W. & Koeffler, H.P. (1997) Molecular analysis of the cyclin-dependent kinase inhibitor genes, p15, 16, 18 and p19 in the myelodysplastic syndromes. Leukemia Research, 3, 235-240.